Analysts have been eager to weigh in on the Healthcare sector with new ratings on 10x Genomics (TXG), Shockwave Medical (SWAV) and Galapagos (GLPG).
10x Genomics (TXG)
In a report released today, Tejas Savant from Morgan Stanley maintained a Buy rating on 10x Genomics, with a price target of $215.00. The company’s shares closed last Monday at $185.23, close to its 52-week high of $201.70.
According to TipRanks.com, Savant is a 4-star analyst with an average return of 23.7% and a 68.4% success rate. Savant covers the Healthcare sector, focusing on stocks such as Ortho Clinical Diagnostics Holdings, Pacific Biosciences, and NanoString Tech.
Currently, the analyst consensus on 10x Genomics is a Strong Buy with an average price target of $204.17, representing a 10.1% upside. In a report issued on February 18, Citigroup also maintained a Buy rating on the stock with a $240.00 price target.
See today’s analyst top recommended stocks >>
Shockwave Medical (SWAV)
Morgan Stanley analyst David Lewis maintained a Hold rating on Shockwave Medical today and set a price target of $130.00. The company’s shares closed last Monday at $130.00, close to its 52-week high of $143.79.
According to TipRanks.com, Lewis is a 5-star analyst with an average return of 18.1% and a 75.6% success rate. Lewis covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Zimmer Biomet Holdings, and Irhythm Technologies.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Shockwave Medical with a $130.00 average price target, which is a -0.4% downside from current levels. In a report issued on February 18, Oppenheimer also maintained a Hold rating on the stock.
Galapagos (GLPG)
In a report released today, Dane Leone from Raymond James upgraded Galapagos to Buy, with a price target of $100.00. The company’s shares closed last Monday at $85.64, close to its 52-week low of $81.89.
According to TipRanks.com, Leone is a 5-star analyst with an average return of 19.5% and a 65.2% success rate. Leone covers the Healthcare sector, focusing on stocks such as Tarsus Pharmaceuticals, Allogene Therapeutics, and Ayala Pharmaceuticals.
Galapagos has an analyst consensus of Hold, with a price target consensus of $102.16.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
